Tighter Aspirin Control Urged For Patients with Diabetes

Taking aspirin increases bleeding risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.

0
The American Diabetes Association, American Heart Association and American College of Cardiology issued a joint statement in June calling for tighter criteria in the use of aspirin as a primary prevention strategy against cardiovascular disease (CVD) for patients with diabetes. This represents a change from the recommendations issued in 2007. "The 2007 joint statement recommended that acetylsalicylic acid, commonly known as aspirin, be used as a primary prevention strategy in patients with diabetes mellitus over 40 years of age or with one or more additional cardiovascular risk factors," explains Leslie Cho, MD, editor-in-chief of Heart Advisor and director of the Womens Cardiovascular Center at Cleveland Clinic.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

LEAVE A REPLY

Please enter your comment!
Please enter your name here